Apical membrane Cl-butyrate exchange: Mechanism of short chain fatty acid stimulation of active chloride absorption in rat distal colon

1994 ◽  
Vol 141 (1) ◽  
Author(s):  
V.M. Rajendran ◽  
H.J. Binder
2004 ◽  
Vol 287 (3) ◽  
pp. C612-C621 ◽  
Author(s):  
Sadasivan Vidyasagar ◽  
Vazhaikkurichi M. Rajendran ◽  
Henry J. Binder

HCO3−secretion has long been recognized in the mammalian colon, but it has not been well characterized. Although most studies of colonic HCO3−secretion have revealed evidence of lumen Cl−dependence, suggesting a role for apical membrane Cl−/HCO3−exchange, direct examination of HCO3−secretion in isolated crypt from rat distal colon did not identify Cl−-dependent HCO3−secretion but did reveal cAMP-induced, Cl−-independent HCO3−secretion. Studies were therefore initiated to determine the characteristics of HCO3−secretion in isolated colonic mucosa to identify HCO3−secretion in both surface and crypt cells. HCO3−secretion was measured in rat distal colonic mucosa stripped of muscular and serosal layers by using a pH stat technique. Basal HCO3−secretion (5.6 ± 0.03 μeq·h−1·cm−2) was abolished by removal of either lumen Cl−or bath HCO3−; this Cl−-dependent HCO3−secretion was also inhibited by 100 μM DIDS (0.5 ± 0.03 μeq·h−1·cm−2) but not by 5-nitro-3-(3-phenylpropyl-amino)benzoic acid (NPPB), a Cl−channel blocker. 8-Bromo-cAMP induced Cl−-independent HCO3−secretion (and also inhibited Cl−-dependent HCO3−secretion), which was inhibited by NPPB and by glibenclamide, a CFTR blocker, but not by DIDS. Isobutyrate, a poorly metabolized short-chain fatty acid (SCFA), also induced a Cl−-independent, DIDS-insensitive, saturable HCO3−secretion that was not inhibited by NPPB. Three distinct HCO3−secretory mechanisms were identified: 1) Cl−-dependent secretion associated with apical membrane Cl−/HCO3−exchange, 2) cAMP-induced secretion that was a result of an apical membrane anion channel, and 3) SCFA-dependent secretion associated with an apical membrane SCFA/HCO3−exchange.


1991 ◽  
Vol 26 (4) ◽  
pp. 442-448 ◽  
Author(s):  
W. E. Longo ◽  
G. H. Ballantyne ◽  
P. E. Savoca ◽  
T. E. Adrian ◽  
A. J. Bilchik ◽  
...  

2009 ◽  
Vol 76 (3) ◽  
pp. 317-325 ◽  
Author(s):  
Alejandra Cardelle-Cobas ◽  
María Fernández ◽  
Nuria Salazar ◽  
Cristina Martínez-Villaluenga ◽  
Mar Villamiel ◽  
...  

Bifidogenic effect and stimulation of short chain fatty acid (SCFA) production by fractions of oligosaccharides with a DP⩾3 and Gal β(1-6) linkages synthesised from lactose or lactulose by Pectinex Ultra SP-L and Lactozym 3000 L HP G were evaluated in human faecal slurries. Results were compared with those obtained for the commercial oligosaccharide mixture Vivinal®-GOS. Quantitative real-time PCR showed that all galacto-oligosaccharide (GOS) fractions stimulated slightly higher bifidobacteria growth than lactose, lactulose and Vivinal®-GOS. GOS fractions promoted the production of total SCFA and acetic acid in a similar way to Vivinal®-GOS and more than glucose, lactose and lactulose. In conclusion, oligosaccharides derived from lactose and lactulose may represent a suitable alternative to lactulose for the design of new functional food ingredients.


Sign in / Sign up

Export Citation Format

Share Document